Abstract
Bacteria have been implicated in the pathogenesis of inflammatory bowel disease (IBD) for several decades, beginning with conventional pathogens such as Shigella, and moving to the current, more “trendy” organisms such as L-forms and mycobacteria. It is only natural to consider bacteria as potential culprits in these diseases, since the intestinal mucosa forms the fragile border between the flora of the lumen and the host’s tissues. In addition, the gut is threatened on a daily basis by microorganisms from the environment that gain passage through vehicles of food and drink. Besides these écologic considerations, the histopathologic features of IBD are strikingly reminiscent of conventional infectious diseases, albeit of an acute and self-limited nature. Ulcerative colitis (UC) is not unlike acute bacillary dysentery, while Crohn’s disease (CD) bears resemblance to intestinal tuberculosis and Yersinia infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Donaldson, RM, Jr. 1964. Normal bacterial population of the intestine and their relation to intestinal function. New England Journal of Medicine 270: 938, 946, 994: 1000, 1050.
Donaldson, RM, Jr. 1970. Small bowel bacterial overgrowth. Advances in Internal Medicine 16: 191–212.
Floch MH, Gorbach SL and Luckey TD. 1970. Symposium: Intestinal microbiology. American Journal of Clinical Nutrition 23: 1425–1609.
Gorbach SL. 1971. Intestinal microflora. Gastroenterology 60: 1110–29.
Simon G, and Gorbach SL. 1985. Intestinal flora and gastrointestinal function. IN: Physiology of the Gastrointestinal Tract.
Maier BR et al. 1972. Shigella, indigenous flora interactions in mice. American Journal of Clinical Nutrition 25: 1433–40.
Gorbach SL, Neale G, Levitan R, and Hepner GW. 1970. Alterations in human intestinal microflora during experimental diarrhea. Gut 11: 1–6.
Bargen JA. 1924. Experimental studies on etiology of chronic ulcerative colitis. Journal of American Medical Association 83: 332–36.
Dragstedt LR, Dack GM, and Kirsner JB. 1941. Chronic ulcerative colitis. A summary of evidence implicating Bacterium necrophorum as an etiologic agent. Annals of Surgery 114: 653–662.
Meleney F. 1941. Discussion. Annals of Surgery 114: 661–62.
Gorbach SL et al. 1968. Studies of intestinal microflora: V. fecal microbial ecology in ulcerative colitis and regional enteritis; relationship to severity of disease and chemotherapy. Gastroenterology 54: 575–87.
Danielsson D, Kjellander J, and Jarnerot G. 1981. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn’s Disease. Scand J Gastroenterol 16:(2): 183–92.
Hudson MJ, Hill MJ, Elliott PR, Berghouse LM, Burnham WR, and Lennard-Jones JE. (1984). The microbial flora of the rectal mucosa and faeces of patients with Crohn’s disease before and during antimicrobial chemotherapy. J Med Microbiol l8(3): 335–45.
Cooke EM. 1967. A quantitative comparison of the fecal flora of patients with ulcerative colitis and that of normal persons. Journal of Pathological Bacteriology 91: 439–44.
Van der Wiel-Korstangie JA, and Winkler KC. 1975. The fecal flora in ulcerative colitis. Journal of Medical Microbiology 8: 491–501.
Van der Merwe M, and Mol GJJ. 1980. A possible role of Eubacterium and Peptostreptococcus species in the etiology of Crohn’s disease. Ant. Van Leeuwenhock 46: 597–93.
Ambrose NS, Johnson M, Burdon DW, and Keighly MRB. 1984. British Journal of Surgery 71: 623–625.
Cooke EM. 1968. Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J. Pathol. Bacteriol. 95: 101–113.
Dickinson RJ, Varian SA, Axon AT, and Cooke EN. 1980. Increased incidence of fecal conforms with in vitro adhesive and invasive properties in patients with ulcerative colitis Abstract. Gut 21(9): 787–92.
Rutgeerts P, Ghoos Y, Vantrappen G, and Eyssen H. 1981. Ileal dysfunction and bacterial overgrowth in patients with Crohn’s disease. Eur J Clin Invest 11(3): 199–206.
Brown WR, and Lee E. 1973. Radioimmunological measurements of naturally occurring bacterial antibodies. I. Human serum antibodies reactive with Escherichia coli in gastrointestinal and immunologic disorders. J Lab Clin Med 82: 125–36.
Tabaqchali S, O’Donoghue DP, and Bettelheim KA. 1978. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 19: 108–13.
Persson S, and Danielsson D. 1979. On the occurrence of serum antibodies to Bacteroides fragilis and serogroups of E. coli in patients with Crohn’s disease. Scand J Infect Dis (Suppl)(19): 61–7.
Brown WR, and Lee E. 1974. Radioimmunological measurements of bacterial antibodies. Human serum antibodies reactive with Bacteroides fragilis and enterococcus in gastrointestinal and immunological disorders. Gastroenterology 66: 1145–53.
Mathews N, Mayberry JF, Rhodes J, et al. 1980. Agglutinins to bacteria in Crohn’s disease. Gut 21: 376–80.
Auer IO, Roder A, Wensinck F, Van de Merwe JP, and Schmidt H. 1983. Selected bacterial antibodies in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 18: 217–23.
Weinsinck F, van de Merwe JP, and Mayberry JF. 1983. Abstract. An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn’s disease, ulcerative colitis and control subjects. Digestion 27(2): 63–9.
Gump D, Caul E, Eade O, Greenberg H, Kapikian, MacPherson B, Mitchell P, Parent K, Richmond S and Beeken W. 1981. Lymphocytotoxic and microbial antibodies in Crohn’s disease and matched controls. Ant. Van Leeuwenhock 46: 597–93.
Onderdonk AB, Steeves RM, Cisneros RL, and Bronson RT. 1984. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infection and Immunity 46(1): 64–7.
Kirsner and Shorter. 1982. Recent developments in “ nonspecific” inflammatory disease. New England Journal of Medicine 306: 775–784, 837-848.
Hurst AF. 1921. Ulcerative colitis. Guy Hospital Republic 71: 26–44.
Mackie TT. 1932. Ulcerative colitis due to chronic infection with Flexner-bacillus. Journal of American Medical Association 98: 1706–10.
Felson J, and Wolarsky W. 1953. Acute and chronic bacilliary dysentery and chronic ulcerative colitis. Journal of American Medical Association 153: 1069–72.
Fradkin WZ. 1937. Ulcerative colitis: Bacterial aspects. New York Journal of Medicine 37: 249–52.
Blaser MJ, Miller FA, Lacher J, and John W. Singleton. 1984. Patients with active Crohn’s disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87: 888–94.
Grange JM, Gibson J, Nassau E, and Kardjito T. 1980. Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis, and Crohn’s disease. Tubercule 61: 145–52
Swabrick FP, Price NL, Kingham JGC et al. 1979. Chlamydia, cytomegalovirus and Yersinia in inflammatory bowel disease. Lancet 11–12.
Taylor-Robinson D, O’Morain CA, and Thomas BJ. 1979. Low frequency of chlamydial antibodies in patients with Crohn’s disease and ulcerative colitis. Lancet i: 1162–65.
Munro J, Mayberry JF, Matthews N, et al. 1979. Chlamydia and Crohn’s disease. Lancet ii: 45–46.
Mardh PA, Ursing B, and Sandgren E. 1980. Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn’s disease, as indicated by microimmunofluorescence antibody test. Acta Pathol Microbiol Scand (B) 88(1): 57–9.
Bartlett JG, Chang TW, Gurwith M, et al. 1978. Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. New England Journal of Medicine 298: 531–4.
Bartlett JG, and Chang TW. 1979. Colitis induced by clostridium difficile. The Reviews of Infectious Diseases.
Trinka F, Markham R, Gurwith et al. 1978. Oral vancomycin for antibiotic association pseudomembranous colitis. Lancet i: 97–8.
Meyers S, Mayer L, Bottone E, et al. 1981. Occurrence of clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80: 697–700.
Wright JM, Adams SP, Gribble MJ, and Bowie WR. 1984. Clostridium difficile in Crohn’s disease. Cancer J Surgery 27(5): 435–7.
Dorman SA, Liggoria E, Winn Jr., WC, and Beeken WL. 1982. Isolation of Clostridium difficile from patients with inactive Crohn’s disease. Gastroenterology 82: 1348–51.
Rolny P, Jarnerot G, and Mollby R. 1083. Occurrence of Clostridium toxin in inflammatory bowel disease. Scand J Gastroenterol l8(1): 61–4.
Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, and Noone P. 1983. Clostridium difficile and inflammatory bowel disease. Gut 24, 713–717.
Falsen E, Kayser B, Nehis L, et al. 1980. Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol 12: 297–300.
Gilligan PH, McCarthy LR, Genta VM. 1981. Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol 14: 26–30.
Chang TO, Lauerman M, and Bartlett JG. 1979. Cytotoxicity assay in antibiotic-associated colitis. Journal of Infectious Diseases 140: 756–70.
Bartlett JG. 1981. Clostridium difficile and inflammatory bowel disease (Editorial). Gastroenterology 80: 863–875.
Parent K, Mitchell P. 1976. Bacterial variants: etiologic agent in Crohn’s disease? Gastroenterology 71: 365–68.
Parent K, Mitchell P. 1978. Cell wall defective variants of Pseudomonas-like (Group Va) bacteria in Crohn’s disease. Gastroenterology 75: 368–72.
Parent K, Mitchell P, and Baltaos E. 1980. Pilot animal pathogenicity studies with cell wall defective pseudomonas-like bacteria isolated from Crohn’s disease patients. Abstract. Gastroenterology 78: 1233.
Belsheim MR, Darwish RZ, Watson WC, and Schieven B. 1983. Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology 85: 364–68.
Graham DY, Yoshimura HH, and Estes MK. 1983. DNA hybridization studies of the association of Pseudomonas maltophilia with inflammatory bowel disease. J Lab Clin Med 101: 940–54.
Whorwell PJ, Davidson IW, Beeken WL, and Wright R. 1978. Search by immunofluorescence for antigens of Rotavirus, Pseudomonas maltophilia, and Mycobacterium kansasii in Crohn’s disease. Lancet 2 (8092 Pt l: 697–8.
Shafii A, Sopher S, Lev M, and Das KM. 1981. An antibody against revertant forms of cell-wall deficient bacterial variant in sera from patients with Crohn’s disease. Lancet 2(8242): 332–4.
Onderdonk AB, Franklin ML, and Cisneros RL. 1981. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infection and Immunity 32(1): 225–31.
Onderdonk AB, and Bartlett JG. 1979. Bacteriological studies of experimental colitis. The American Journal of Clinical Nutrition 32: 258–2655.
Burnham WR, Lennard-Jones JE, Stanford et al. 1978. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 2: 693–96.
Stanford JL. 1978. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 693–96.
Stanford JL. 1981. Acid fast organisms in Crohn’s disease and ulcerative colitis. In Recent Advances in Crohn’s Disease. AS Pena, IT Weterman, CC Booth, W Strober (eds). The Hague, Martinus Nijhoff Publishers, pp 278–282.
White SA: Investigation into the density of acid fast organisms located from Crohn’s disease. 1981. In Recent Advances in Crohn’s Disease. AS Pena, IT Weterman, CC Booth, W Strober (eds). The Hague, Martinus, Nijhoff Publishers, pp 278–282.
White S. Nassau E, and Burnham W. and Stanford J. 1978. Lennard-Jones JE: Further evidence for a mycobacterial aetiology of Crohn’s disease. Gut 19: A443–444.
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal R, and Coutu JA. 1984. Possible role of mycobacteria in inflammatory bowel disease. Digestive Diseases and Sciences, Vol. 29, No 12, pp 1073–1079.
Van Kruiningen HJ, Chiodini RJ, Thayer WR, Coutu JA, Merkal RS, and Runnels PL. Experimental disease in goats induced by mycobacterium from a patient with Crohn’s disease. Gastroenterology 30: A–122, 1985. Abstract No. 487.
Thayer WR, Coutu JA, Chiodini RJ, Van Kruiningen HJ, and Merkal R. 1984. Possible role of mycobacteria in inflammatory bowel disease. II Mycobacterial antibodies in Crohn’s disease. Digestive Diseases and Sciences, Vol. 29, No. 12, pp. 1080–1085.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers
About this chapter
Cite this chapter
Gorbach, S.L. (1986). Bacterial Etiology of Inflammatory Disease. In: Rachmilewitz, D. (eds) Inflammatory Bowel Diseases 1986. Developments in Gastroenterology, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4269-1_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-4269-1_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8396-6
Online ISBN: 978-94-009-4269-1
eBook Packages: Springer Book Archive